[1] American Cancer Society, “Cancer Facts & Figures 2012,” American Cancer Society, Atlanta, 2012.
[2] T. Kosaka, A. Miyajima, S. Shirotake, E. Kikuchi and M. Oya, “Phosphorylated Akt Up-Regulates Angiotensin II Type-1 Receptor Expression in Castration Resistant Prostate Cancer,” Vol. 71, No. 15, Prostate, 2011, pp. 15010-1517.
[3] N. Queisser, P. I. Oteiza, H. Stopper, R. G. Oli and N. Schupp, “Aldosterone Induces Oxidative Stress, Oxidative DNA Damage and NF-κB-Activation in Kidney Tubule Cells,” Molecular Carcinogenesis, Vol. 50, No. 2, 2011, pp. 123-135. doi:10.1002/mc.20710
[4] K. Hoshino, H. Ishiguro, J. I. Teranishi, et al., “Regulation of Androgen Receptor Expression through Angiotensin II Type 1 Receptor in Prostate Cancer Cells,” Prostate, Vol. 71, No. 9, 2010, pp. 964-975. doi:10.1002/pros.21312
[5] K. Okamoto, H. Tajima and T. Ohta, et al., “The Role of Renin-Angiotensin System Independent Angiotensin II Production in Progression and Fibrosis of Intrahepatic Cholangiocarcinoma,” Japanese Journal of Cancer and Chemotherapy, Vol. 37, No. 12, 2010, pp. 2231-2233.
[6] M. Fujita, I. Hayashi, S. Yamashina, M. Itoman and M. Majima, “Blockade of Angiotensin AT1a Receptor Signaling Reduces Tumor Growth, Angiogenesis, and Metastasis,” Biochemical and Biophysical Research Communications, Vol. 294, No. 2, 2002, pp. 441-447. doi:10.1016/S0006-291X(02)00496-5
[7] S. Greco, A. Muscella, M. G. Elia, et al., “Angiotensin II Activates Extracellular Signal Regulated Kinases via Protein Kinase C and Epidermal Growth Factor Receptor in Breast Cancer Cells,” Journal of Cellular Physiology, Vol. 196, No. 2, 2003, pp. 370-377. doi:10.1002/jcp.10313
[8] S. A. Alves Correa, S. M. Ribeiro de Noronha, N. C. Nogueira-de-Souza, et al., “Association between the Angiotensin-Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms and Breast Cancer among Brazilian Women,” Journal of the Renin-Angiotensin-Aldosterone System, Vol. 10, No. 1, 2009, pp. 51-58. doi:10.1177/1470320309102317
[9] A. P. Mendizábal-Ruiz, J. A. Morales, X. Castro Marti Nez, et al., “RAS Polymorphisms in Cancerous and Benign Breast Tissue,” Journal of the Renin-AngiotensinAldosterone System, Vol. 12, No. 2, 2011, pp. 85-92. doi:10.1177/1470320310383735
[10] S. Namazi, A. Monabati, S. Ardeshir-Rouhani-Fard and N. Azarpira, “Association of Angiotensin I Converting Enzyme (Insertion/Deletion) and Angiotensin II Type 1 Receptor (A1166C) Polymorphisms with Breast Cancer Prognostic Factors in Iranian Population,” Molecular Carcinogenesis, Vol. 49, No. 12, 2010, pp. 1022-1030. doi:10.1002/mc.20685
[11] M. del Pilar Carrera, M. J. Ramírez-Expósito, M. D. Mayas, M. J. García and J. M. Martínez-Martos, “Mammary Renin-Angiotensin System-Regulating Aminopeptidase Activities Are Modified in Rats with Breast Cancer,” Tumor Biology, Vol. 31, No. 6, 2010, pp. 583-588. doi:10.1007/s13277-010-0072-2
[12] B. Krishnan, T. L. Smith, P. Dubey, et al., “Angiotensin(1-7) Attenuates Metastatic Prostate Cancer and Reduces Osteoclastogenesis,” Prostate, Vol. 73, No. 1, 2013, pp. 71-82. doi:10.1002/pros.22542
[13] D. R. Soto-Pantoja, J. Menon, P. E. Gallagher and E.A. Tallant, “Angiotensin-(1-7) Inhibits Tumor Angiogenesis in Human Lung Cancer Xenografts with a Reduction in Vascular Endothelial Growth Factor,” Molecular Cancer Therapeutics, Vol. 8, No. 6, 2009, pp. 1676-1683. doi:10.1158/1535-7163.MCT-09-0161
[14] P. Economopoulou, V. G. Kaklamani and K. Siziopikou, “The Role of Cancer Stem Cells in Breast Cancer Initiation and Progression: Potential Cancer Stem CellDirected Therapies,” Oncologist, Vol. 17, No. 11, 2012, pp. 1394-1401. doi:10.1634/theoncologist.2012-0163
[15] S. M. R. Noronha, S. A. A. Correa-Noronha, I. H. Russo, R. L. de Cicco, J. Santucci-Pereira and J. Russo, “Human Chorionic Gonadotropin and a 15 Amino Acid hCG Fragment of the Hormone Induce Downregulation of the Cytokine IL-8 Receptor in Normal Breast Epithelial Cells,” Hormone Molecular Biology and Clinical Investigation, Vol. 6, No. 3, pp. 241-245.
[16] C. A. Santos, “Papel da Angiotensina II e Angiotensina-(1-7) na Proliferacao E Progressao do Cancer de Mama,” MsC. Thesis, Universidade Federal de S?o Paulo (UNIFESPEPM), S?o Paulo, 2013.
[17] ESR1, “Estrogen Receptor 1 [Homo sapiens (Human)]; Gene ID: 2099,” 2013. http://www.ncbi.nlm. nih.gov/gene/2099
[18] N. Hevir, N. Trost, N. Debeljak and T. L. Rizner, “Expression of Estrogen and Progesterone Receptors and Estrogen Metabolizing Enzymes in Different Breast Cancer Cell Lines,” Chemico-Biological Interactions, Vol. 191, No. 1-3, 2011, pp. 206-216. doi:10.1016/j.cbi.2010.12.013
[19] J. Qin, X. Chen, X. Xie, M. J. Tsai and S. Y. Tsai, “COUP-TFII Regulates Tumor Growth and Metastasis by Modulating Tumor Angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 8, 2010, pp. 3687-3692. doi:10.1073/pnas.0914619107
[20] E. Moré, T. Fellner, H. Doppelmayr, et al., “Activation of the MAP Kinase Pathway Induces Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) Expression in Human Breast Cancer Cell Lines,” Journal of Endocrinology, Vol. 176, No. 1, 2003, pp. 83-94. doi:10.1677/joe.0.1760083
[21] P. Peixoto, V. Castronovo, N. Matheus, et al., “HDAC5 Is Required for Maintenance of Pericentric Heterochromatin, and Controls Cell-Cycle Progression and Survival of Human Cancer Cells,” Cell Death & Differentiation, Vol. 19, No. 7, 2012, pp. 1239-1252. doi:10.1038/cdd.2012.3
[22] H. Kocdor, M. A. Kocdor, J. Russo, et al., “Human Chorionic Gonadotropin (hCG) Prevents the Transformed Phenotypes Induced by 17 Beta-Estradiol in Human Breast Epithelial Cells,” Cell Biology International, Vol. 33, No. 11, 2009, pp. 1135-1143. doi:10.1016/j.cellbi.2009.07.002
[23] K. L. Cook, L. J. Metheny-Barlow, E. A. Tallant, et al., “Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors,” Cancer Research, Vol. 70, No. 21, 2010, pp. 8319-8328. doi:10.1158/0008-5472.CAN-10-1136